Therapy Areas
Sanofi to support J&J's COVID-19 vaccine manufacturing efforts
22 February 2021 -

French, multinational pharmaceutical company Sanofi SA said on 22 February 2021 that it will provide COVID-19 vaccine manufacturing support to US pharmaceutical company Johnson & Johnson Inc (J&J), Reuters news agency reported on Monday.

Reportedly, once authorised, Sanofi will provide Johnson & Johnson access to the infrastructure and expertise of its vaccine manufacturing plant in Marcy l'Etoile, France, to formulate and fill vials of Johnson & Johnson's Janssen COVID-19 vaccine candidate in 2021.

These vials will be filled at a rate of approximately 12 million doses per month, Sanofi added.